Genea Biomedx

Peter Svalander is a Medical Doctor and Associate Professor in Sweden, and a Board-certified Highcomplexity Clinical Laboratory Director (HCLD, ABB) in the USA. His extensive background in business start-ups, expansions, and technology includes roles as Founder/CEO of Vitrolife a world-leader in the field of fertility treatment and EHC a preventive cardiovascular diagnostic clinic, both in Sweden. Over the past 30 years he has held executive and medical positions in Sweden, USA, UK, Switzerland and Mauritius.

Teija Peura’s background is in academic science, with a PhD and post-doctoral roles in animal reproductive biotechnology in Finland and Australia. Since 2003, she has transitioned from the Sydney IVF/Genea R&D lab to leading Biomedx product development, then into business development, and eventually returning to a scientific role.

Tom Beckitt, with expertise in Biochemistry, Chemistry, and Clinical Trials, has extensive experience in the pharmaceutical, veterinary, and medical device industries in the UK and Australia. He specialises in drug discovery, vaccine development, and assisted reproductive technologies. Since joining Genea Biomedx in 2015, he has played a key role in the strategic growth and development of the company

Clara is a global marketing and communications leader with over 15 years of experience in the healthcare and biotechnology sectors. With a background at IVI RMA Global and ATERSA Grupo Elecnor, she has led international marketing strategies across multiple regions. At Genea Biomedx, she drives brand positioning, scientific engagement, and digital innovation, working closely with R&D and product teams to support fertility specialists worldwide.